SPARK Advisory Partners is pleased to announce that it has advised AIM quoted TyraTech, Inc. (AIM: TYR and TYRU) on its conditional Placing and Subscription to raise £3.16 million. TyraTech, a life sciences company which focuses on nature-derived insect and parasite control products, will primarily use the funds raised to increase the market penetration of the Company’s Vamousse product range, launch a new product range for use in animal production facilities and as general working capital.
https://www.sparkadvisorypartners.com/images/spark-AP-logo.png 0 0 developer https://www.sparkadvisorypartners.com/images/spark-AP-logo.png developer2015-11-06 14:33:122017-01-31 13:10:02SPARK acts for TyraTech, Inc in relation to its Placing and Subscription
Offices in London and Leeds
We are based in the City of London but also have an office in Leeds which makes it easy for us to provide our services wherever you may be. We offer our services to clients anywhere in the United Kingdom, plus we also have many clients overseas. In addition to our London based clients, our team has recently dealt with clients in Leeds, Manchester, Sheffield, Birmingham, Nottingham, Bristol, Glasgow, Edinburgh plus many other UK cities.
- SPARK is recruiting at Analyst through Senior Associate” level – prior experience essential24th February 2021 - 7:14 pm
- SPARK has acted as Financial and Nominated Adviser to MyHealthChecked plc in respect of its Placing and Subscription18th February 2021 - 10:30 am
- SPARK acts as Sponsor to Draper Esprit VCT plc16th February 2021 - 10:39 am
- SPARK acts as financial adviser to Two Shields Investments plc on reverse takeover of BrandShield Limited1st December 2020 - 9:17 am